Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm. [electronic resource]
Producer: 19900628Description: 2631-4 p. digitalISSN:- 0008-543X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Drug Evaluation
- Etoposide -- administration & dosage
- Female
- Humans
- Ifosfamide -- administration & dosage
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Prognosis
- Randomized Controlled Trials as Topic
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.